Manmohan Reddy LELETI,Dillon Harding MILES,Jay Patrick POWERS,Brandon Reid ROSEN,Ehesan Ul SHARIF,Rhiannon THOMAS-TRAN
申请号：
US16610812
公开号：
US20200069689A1
申请日:
2018.05.03
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Compounds that inhibit at least one of the A2A and A2B adenosine receptors, and compositions containing the compound and methods for synthesizing the compound, are described herein. Also described are the use of such compounds and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by the adenosine A2A receptor and/or the adenosine A2B receptor.
